UnitedHealth Group Incorporated
Profit after direct costs
Core business profitability
Bottom line profitability
Top line growth rate
Flow of revenue through cost categories to net income
| Item | Trend | 2021 | 2022 | 2023 | 2024 | 2025 | YoY Change |
|---|---|---|---|---|---|---|---|
Total Revenue | 287.60B | 324.16B | 371.62B | 400.28B | 447.57B | 11.8% | |
| Cost of Revenue | (217.94B) | (244.54B) | (280.66B) | (310.88B) | (364.65B) | 17.3% | |
Gross Profit | 69.65B | 79.62B | 90.96B | 89.40B | 82.92B | -7.3% | |
| Operating Expenses | |||||||
| Research & Development | — | — | — | — | — | — | |
| Selling, General & Administrative | — | — | — | — | — | — | |
| Depreciation & Amortization | (3.10B) | (3.40B) | (3.97B) | (4.10B) | (4.36B) | 6.4% | |
Operating Income (EBIT) | 23.97B | 28.43B | 32.36B | 32.29B | 18.96B | -41.3% | |
| Non-Operating Items | |||||||
| Interest Income | — | — | — | — | — | — | |
| Interest Expense | (1.66B) | (2.09B) | (3.25B) | (3.91B) | (4.00B) | 2.5% | |
| Other Income/Expenses (Net) | -1.66B | -2.09B | -3.25B | -12.22B | -4.27B | -65.1% | |
Income Before Tax | 22.31B | 26.34B | 29.11B | 20.07B | 14.70B | -26.8% | |
| Income Tax Expense | (4.58B) | (5.70B) | (5.97B) | (4.83B) | (1.89B) | -60.9% | |
Net Income | 17.29B | 20.12B | 22.38B | 14.40B | 12.06B | -16.3% | |
| Per Share Metrics | |||||||
| Earnings Per Share (Basic) | $18 | $22 | $24 | $16 | $13 | -15.4% | |
| Weighted Avg Shares Outstanding | 943.00M | 934.00M | 928.00M | 929.00M | 910.00M | -2.0% | |
| Weighted Avg Shares Outstanding (Diluted) | 956.00M | 950.00M | 938.00M | 929.00M | 910.00M | -2.0% | |
EBITDA | 27.07B | 31.84B | 36.33B | 28.08B | 23.06B | -17.9% |
Explore UNH
UNH in the Healthcare
Mega Cap